DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Astex Pharmaceuticals
Astex Pharmaceuticals
PULSE: Speaker Biographies March 2019
Guidelines with Regard to the Composition, Calculation and Management of the Index
Feasibility and First Reports of the MATCH-R Repeated Biopsy Trial At
Disclosure of Financial Relationships April 10-15 • May 17-21
Supergen, Inc. Changes Name to Astex Pharmaceuticals, Inc., Announces New Stock Ticker Symbol and New Website
Expert Connect All Relationships Are Considered Compensated
6 June 2016 NOT for RELEASE, PUBLICATION OR DISTRIBUTION
Biocentury the BERNSTEIN REPORT on BIOBUSINESS
Conference Handbook 2013
Astex Achieves Milestones in GSK Collaboration
2020 Medicines in Development ꟷ Cancer
Translating UK Scientific Excellence Into Global Therapeutic Strategies Partnering for Scientifi C Leadership
Biotech in Europe Investor Forum
Table of Contents
Astex Pharmaceuticals – Structural Biology Revolutionises Drug Discovery
Disclosure of Financial Relationships April 10-15 • May 17-21
Auditor Disclosure Data.Xlsx
Vernalis Plc Vernalis ANNUAL REPORT and ACCOUNTS 2015/16
Top View
EUROPEAN LIFE SCIENCE CEO FORUM CEO SCIENCE LIFE EUROPEAN WELCOME SPEAKERS PRESENTING COMPANIES EXHIBITORS SPONSORS & SUPPORTERS ORGANISERS T Back :: Next U
Activation of the Anti-Tumor Immune Responses of Γ9δ2 T Cells In
Supergen and Astex Therapeutics Enter Definitive Merger Agreement
Acquisitions • Alliances • Financing
Edison Healthcare Quarterly August 2012
Volunteer Disclosure Report
The UK Pharmaceutical Sector an Overview